Momentus Stock (MNTS) Rockets 70% on NASA Contract
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Momentus noted that NASA intends to award a contract for a follow-up study in September. The company is one of the two that the U.S. space agency is considering for this additional contract. The company has used its flagship Vigoride orbital service vehicle in the first portion of the study and would continue to do so in the follow-up study.
John Rood, CEO of Momentus, said, 'We're honored to be entrusted by NASA to help mature these cutting-edge robotics systems. Space robotics is rapidly becoming a strategic capability that we expect to leverage in the future to support customers in the commercial and national security sectors.'
Momentus Stock Movement Today
Momentus stock was up 69.37% in pre-market trading on Wednesday. However, the company's shares have fallen 86% year-to-date and 83.91% over the past 12 months. News of its contract with NASA brought heavy trading to MNTS stock, with some 60.5 million shares having changed hands, which is well above its three-month daily average of about 2.08 million units.
Is Momentus Stock a Buy, Sell, or Hold?
Turning to Wall Street, coverage of Momentus is lacking. Luckily, TipRanks' AI analyst Spark has it covered. Spark rates MNTS stock an Underperform (40) with a $1 price target. It cites 'significant financial challenges with declining revenues and high operating losses' as reasons for this stance.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 hours ago
- Yahoo
Where Will Oklo Be in 3 Years?
Key Points Nuclear power is experiencing a resurgence amid rising energy demand, primarily driven by AI. Oklo is pioneering advanced nuclear fuel technologies, including its Aurora powerhouse product line. It's awaiting regulatory approval, and plant operations may not begin until 2027 at the earliest. 10 stocks we like better than Oklo › Nuclear energy stocks are heating up, and for good reason. This year, U.S. President Donald Trump has put nuclear power in the spotlight, and countries around the globe have pledged to triple their nuclear capacity by 2050. The excitement even extends beyond our planet, with Sean Duffy, Secretary of the Department of Transportation and acting National Aeronautics and Space Administration (NASA) administrator, floating the idea of using nuclear power on the Moon. What's fueling this nuclear renaissance? The unstoppable rise of artificial intelligence (AI). As AI systems grow more powerful, their appetite for energy soars, and nuclear is emerging as a leading contender to meet this demand. Enter Oklo (NYSE: OKLO), an upstart innovator in the nuclear sector. Founded in 2013, Oklo develops small modular reactors (SMRs) and innovative nuclear fuel solutions. Here's what investors can expect from Oklo over the next few years. Oklo's secret sauce in the nuclear space Oklo's Aurora powerhouse product line is based on proven liquid-metal-cooled sodium fast reactor technology, specifically leveraging the technology of the Experimental Breeder Reactor-II (EBR-II), which operated for over 30 years at the Idaho National Laboratory (INL). The Aurora powerhouse product line is designed to produce 15 to 75 megawatts electric (MWe) and has the potential to expand to 100 MWe and higher. As a metal-fueled fast reactor, Aurora powerhouses are designed to operate by harnessing the power of high-energy, or "fast," neutrons. This enables them to tap into the vast energy reserves remaining in existing used nuclear fuel from conventional nuclear power plants. Oklo's reliance on mature and validated technology is a key differentiator, as it allows it to move directly into commercialization without the need for a costly and time-consuming demonstration plant. The Aurora is designed from the ground up as a full commercial deployment. What to watch for in the next few years Oklo was the first advanced fission company to submit a custom Combined Operating License Application (COLA) to the U.S. Nuclear Regulatory Commission (NRC) in 2020. The NRC initially denied the application in 2022, citing the need for more information. The company initiated a pre-application readiness assessment with the NRC in early 2025 for its Aurora-INL Powerhouse COLA, indicating it is on track. Oklo plans to submit the first phase of this application by the end of the year. The NRC's review process can take two to four years, especially with Oklo's unconventional fast reactor design. If everything stays on schedule, Oklo could receive the green light from the NRC by 2027 or 2028, paving the way for plant operations to begin soon after. Oklo has also submitted its Licensed Operator Topical Report to the NRC, proposing a model where operators are licensed for the Aurora powerhouse technology rather than individual sites. This approach is a departure from traditional nuclear plant models and aims to streamline approvals and reduce timelines, enabling operators to monitor multiple powerhouses centrally. By strategically submitting topical reports like this one, Oklo is laying the regulatory foundation for faster licensing pathways. This "regulatory efficiency is central to Oklo's plan for scalable deployment across its fleet," Jacob Dewitte, co-founder and CEO, told investors during its first-quarter earnings call. A high-risk stock that may not generate meaningful cash flow for years With all this said, Oklo is still in its early stages of development and doesn't have a commercially available product at the moment. The company will continue to incur costs as it obtains its license and builds out its first reactors. It expects to spend $65 million to $80 million on operations this year. Analysts covering Oklo don't think it will generate revenue in 2027 -- between $5.2 million and $18 million in 2028. Meanwhile, they project the company will continue to rack up losses and may not be profitable until 2030 at the earliest. Oklo's long-term vision is compelling, especially given the rising demand for clean, reliable energy. However, Oklo's path to profitability remains years out and hinges on regulatory milestones, technological execution, and market adoption, making it a high-risk stock for investors buying it today. Should you buy stock in Oklo right now? Before you buy stock in Oklo, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Oklo wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,544!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,113,059!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Courtney Carlsen has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Where Will Oklo Be in 3 Years? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
After repeated explosions, new test for Musk's megarocket
Elon Musk's SpaceX announced Friday that its Starship megarocket is scheduled to blast off on a new test flight next weekend after recent attempts have ended in fiery explosions. The biggest and most powerful launch vehicle in history is planned to return Americans to the Moon -- and is central to the dreams of colonizing Mars envisioned by Musk, the world's richest person. But repeated explosions that sent debris raining down over Caribbean islands and disrupted flights have piled pressure onto SpaceX to pull off a smoother trial run. The rocket's 10th test flight is set to launch as soon as August 24 from the company's Starbase facility in Texas, SpaceX said on its website. During two test flights earlier this year, the rocket's upper stage -- which is the spacecraft intended to carry crew and cargo -- erupted in fiery cascades not long after launch. Starship managed to make it to space during the last test in late May, however it then blew up when a fuel leak caused it to lose control. The rocket's propulsion system was also supposed to execute a planned splashdown in the Gulf of Mexico -- but it disintegrated before reaching the water. Standing 403 feet (123 meters) tall, the black-and-white behemoth is designed to eventually be fully reusable and launch at relatively low cost. SpaceX has been betting that its "fail fast, learn fast" ethos -- which helped it dominate commercial spaceflight -- will once again pay off. But the latest string of setbacks, which also includes an explosion during a routine ground test in June, has raised serious questions about Starship's progress. Musk -- who is known for making extremely ambitious proposals -- maintains that the rocket will launch its first uncrewed missions to Mars next year. SpaceX has also been sharply criticized over the impact its launches have on people and the environment near where its rockets blast off. In June, Mexican President Claudia Sheinbaum threatened to sue SpaceX over falling debris and contamination from its launches. More Starship tests are expected in the coming months, however, after the US aviation regulator approved the number of its annual launches increasing from five to 25. cha/dl/mlm
Forbes
a day ago
- Forbes
The Prototype: AI Tools May Degrade Doctors' Skills
In this week's edition of The Prototype, we look at the risk of depending on AI to 'think' for you, mass-producing satellites, a startup helping NASA avoid space junk, and more. To get The Prototype in your inbox, sign up here . A study published this week in The Lancet examined the impact of an AI tool for colonoscopies on the skills of doctors. The researchers tested doctors' abilities to find certain abnormalities in patients for three months before using AI, then tested them again after they'd used the tool for three months. They found that doctors' ability to spot those abnormalities on their own degraded after using AI. And while that might not be a big deal a few decades down the road when AI-assisted detections are the norm, it does pose a problem right now, because these tools aren't universal. A doctor accustomed to using AI at one hospital might find their performance declines working at a hospital that hasn't adopted it yet. It also raises larger questions about letting AI do your 'thinking' for you, because what's lost might be more than one particular skill. Studies have shown, for example, that overreliance on GPS for driving could degrade your spatial memory. As we enter a brave new world of AI, it will be increasingly important to not only know how to use it, but also when not to use it. Stay tuned. Apex Wants To Bring Henry Ford-Style Mass Production To Satellites S atellite manufacturing has long been a bespoke business with spacecraft customized for the missions they are sent on. Elevated costs and delays come with the territory. With more and more small satellites being launched into low-Earth orbit, Lost Angeles-based Apex has developed standardized spacecraft it says are a faster and more affordable option. The company is marketing three standardized satellite bodies with power and control systems that can be quickly customized by clients with sensors and payloads. Like, say, weapons to shoot down intercontinental ballistic missiles, as envisioned for President Trump's Golden Dome. Similar to automakers, Apex offers different versions of its satellites, with options like more power, a fancier communications system and a choice between electrical or chemical propulsion. 'You either take it or you leave it,' CEO Ian Cinnamon said. Read the whole story at Forbes . DISCOVERY OF THE WEEK: DEVICE LETS USERS COMMUNICATE WITH THOUGHTS Neurological disorders like ALS can make it difficult for people to communicate. And while there are devices that can help them speak, they're often much slower than the speech that people take for granted. A team of researchers have invented a new device that may change this: a computer device implanted in the brain that can pick up the neural activity associated with speech-based thinking and translate it into words. The technology is still in its infancy, but opens the door to brain-computer interfaces that may one day give patients the ability to communicate as quickly as they think. FINAL FRONTIER: LEOLABS WANTS TO HELP NASA AVOID SPACE JUNK Menlo Park, Calif.-based space startup LeoLabs has entered into an agreement for NASA to evaluate its data for use in evaluating the risk of satellite and spacecraft collisions. The goal would be to integrate LeoLabs' data, which is collected by multiple radar systems around the world, with the Air Force radar systems that NASA currently uses to track objects in space. (To learn more about LeoLabs, check out a story I wrote about the company a few years back.) FORBES CALLED IT: HELPING DOGS LIVE LONGER Every year, Forbes selects 25 VC-backed companies for our Next Billion-Dollar Startups List, highlighting those whose growth puts them on track to become worth $1 billion or more. Making the list this year is biotech startup Loyal, which is developing pills that could extend dogs' lifespans. The company is currently testing its medication on several hundred canines in a clinical trial, with hopes of bringing it to market soon. We've had our eye on Loyal for a few years now: its founder, Celine Halioua, is an alumna of our 30 Under 30 list, and I wrote about her company's progress a couple of years ago. If Loyal is successful in extending the life of dogs, its next goal will be even more ambitious: extending ours. 'I think the general public will be blown away when they realize they can go to the vet and get a drug to extend their dogs' lifespan,' Halioua told my colleague Amy Feldman. 'Then they'll ask, 'Why can't I do this for my grandma?'' WHAT ELSE I WROTE THIS WEEK Earlier this week, I wrote about biotech startup Tahoe Therapeutics, which just raised $30 million in investment to support scaling up its dataset of how different molecules interact with living cells. Their goal? To train AI models to simulate cells as a way to accelerate the discovery of new medicines. Right now, data is the limiting factor in training AI, but recently the company released a dataset with 100 million cellular datapoints to improve those models. In my other newsletter, InnovationRx, Amy Feldman and I looked at how misinformation about vaccines led to the recent shooting at the CDC, a company building programmable mRNA to fight cancer, Robert F. Kennedy Jr.'s fight with a medical journal, and more. SCIENCE AND TECH TIDBITS The federal government has pulled funds for California's high-speed rail, but the project may have an unlikely savior: AI data centers. Google is teaming up with pollster Scott Rasmussen for a project that would use AI to produce better political polling outcomes. Researchers at Texas A&M have developed a new carbon-fiber material that can heal itself when broken and is harder than steel. Scientists have developed a 'skin in a syringe'—a gel that contains living skin cells–that can be 3D printed into a skin graft and applied to a wound, enabling burns to heal without leaving scars. PRO SCIENCE TIP: THINK OUTSIDE THE SEARCH ENGINE Have you ever fired up Google during a brainstorming session to help your teammates generate ideas? You might think twice about doing so again. A recent study explored how creativity varies between groups when one has access to the internet and one doesn't. 244 people were divided into small groups with half of them given access to a search engine. The groups were tasked with coming up with as many ideas as possible for using a particular object. One object didn't have many results on Google when searching; the other had many. The researchers found that those who didn't use Google tended to come up with more creative and effective ideas than those who did. What's more, when there were a lot of Google search results, the groups tended to converge on the top answers given rather than coming up with their own creative responses. WHAT'S ENTERTAINING ME THIS WEEK I'm a few episodes into the new season of King of the Hill , the first since it was cancelled in 2010. The show's creators chose to advance the series in time a little bit, meaning that we get to see Hank and Peggy Hill struggling to navigate retirement while their son navigates early adulthood. If you're a fan of the original iteration, you won't be disappointed by the new episodes. And my favorite touch? In the year 2025, resident conspiracy theorist character Dale Gribble doesn't have his craziest ideas ignored anymore. Instead, he's got a Substack and a bunch of willing subscribers. MORE FROM FORBES Forbes Meet The Mastermind Behind The $1.9 Billion Poppi Deal By Chloe Sorvino Forbes As Trump Rolls Back Federal Financial Regulation, Blue State Regulators Step Up By Jeff Kauflin Forbes Why Paramount's $7.7 Billion UFC Gamble Will Pay Off By Matt Craig
